Literature DB >> 18456899

Dosimetric models used in the Alpha-Risk project to quantify exposure of uranium miners to radon gas and its progeny.

J W Marsh1, Y Bessa, A Birchall, E Blanchardon, W Hofmann, D Nosske, L Tomasek.   

Abstract

The European project Alpha-Risk aims to quantify the cancer and non-cancer risks associated with multiple chronic radiation exposures by epidemiological studies, organ dose calculation and risk assessment. In the framework of this project, mathematical models have been applied to the organ dosimetry of uranium miners who are internally exposed to radon and its progeny as well as to long-lived radionuclides present in the uranium ore. This paper describes the methodology and the dosimetric models used to calculate the absorbed doses to specific organs arising from exposure to radon and its progeny in the uranium mines. The results of dose calculations are also presented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456899     DOI: 10.1093/rpd/ncn119

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  11 in total

1.  Lung cancer mortality in the European uranium miners cohorts analyzed with a biologically based model taking into account radon measurement error.

Authors:  W F Heidenreich; L Tomasek; B Grosche; K Leuraud; D Laurier
Journal:  Radiat Environ Biophys       Date:  2012-05-24       Impact factor: 1.925

2.  Stochastic rat lung dosimetry for inhaled radon progeny: a surrogate for the human lung for lung cancer risk assessment.

Authors:  R Winkler-Heil; M Hussain; W Hofmann
Journal:  Radiat Environ Biophys       Date:  2015-02-28       Impact factor: 1.925

3.  Kidney cancer mortality and ionizing radiation among French and German uranium miners.

Authors:  Damien Drubay; Sophie Ancelet; Alain Acker; Michaela Kreuzer; Dominique Laurier; Estelle Rage
Journal:  Radiat Environ Biophys       Date:  2014-05-24       Impact factor: 1.925

4.  Effect of site-specific bronchial radon progeny deposition on the spatial and temporal distributions of cellular responses.

Authors:  Arpád Farkas; Werner Hofmann; Imre Balásházy; István Szoke; Balázs G Madas; Mona Moustafa
Journal:  Radiat Environ Biophys       Date:  2011-02-15       Impact factor: 1.925

5.  Mortality from internal and external radiation exposure in a cohort of male German uranium millers, 1946-2008.

Authors:  M Kreuzer; F Dufey; D Laurier; D Nowak; J W Marsh; M Schnelzer; M Sogl; L Walsh
Journal:  Int Arch Occup Environ Health       Date:  2014-08-19       Impact factor: 3.015

6.  Radon and risk of death from cancer and cardiovascular diseases in the German uranium miners cohort study: follow-up 1946-2003.

Authors:  Michaela Kreuzer; B Grosche; M Schnelzer; A Tschense; F Dufey; L Walsh
Journal:  Radiat Environ Biophys       Date:  2009-10-24       Impact factor: 1.925

7.  Radon-associated lung cancer risk among French uranium miners: modifying factors of the exposure-risk relationship.

Authors:  Blandine Vacquier; Agnès Rogel; Klervi Leuraud; Sylvaine Caer; Alain Acker; Dominique Laurier
Journal:  Radiat Environ Biophys       Date:  2008-10-24       Impact factor: 1.925

8.  External gamma radiation and mortality from cardiovascular diseases in the German WISMUT uranium miners cohort study, 1946-2008.

Authors:  M Kreuzer; F Dufey; M Sogl; M Schnelzer; L Walsh
Journal:  Radiat Environ Biophys       Date:  2012-11-29       Impact factor: 1.925

9.  Radon and risk of extrapulmonary cancers: results of the German uranium miners' cohort study, 1960-2003.

Authors:  M Kreuzer; L Walsh; M Schnelzer; A Tschense; B Grosche
Journal:  Br J Cancer       Date:  2008-11-11       Impact factor: 7.640

10.  PUMA - pooled uranium miners analysis: cohort profile.

Authors:  Estelle Rage; David B Richardson; Paul A Demers; Minh Do; Nora Fenske; Michaela Kreuzer; Jonathan Samet; Charles Wiggins; Mary K Schubauer-Berigan; Kaitlin Kelly-Reif; Ladislav Tomasek; Lydia B Zablotska; Dominique Laurier
Journal:  Occup Environ Med       Date:  2020-01-31       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.